Sign in
TerminatedNo phase

Effects of Spinal Cord Stimulation on Gait in Patients With Parkinson´s Disease

Key facts

Who runs it
University of Sao Paulo General Hospital
Where
Brazil1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
8 people enrolled
Started
30 Nov 2021
Ended
1 Mar 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Active spinal cord stimulation
  • Sham spinal cord stimulation
Record updated
13 May 2024
Why it stopped
No effect identified with two thirds of expected sample size completing study, one patient presented adverse perioperative event.

Who can take part

Age
21 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Diagnosed Parkinson´s Disease with Hoehn Yahr scale between 2,5 and 4,0
  • Main complaint of balance or freezing of gait
  • Score of 2 or more on subitem 3.11 of the MDS UPDRS scale concerning Freezing of Gait severity
  • Capable of informed consent

Who cannot take part

  • Uncontrolled or serious comorbidities such as uncontrolled diabetes mellitus, renal disease, anticoagulation, immunosuppression or other medical conditions that present a contraindication for SCS surgery
  • Psychosis, uncontrolled depression (BDI >14) or anxiety disorder (BAI >14)
  • Frequent lower limb, lower back or hip pain scoring 3 or more on visual analog scale

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Spinal cord stimulation (SCS) for Parkinson´s disease (PD) has been studied for a decade but consensus on efficacy is still lacking, with the previous stimulation standard paresthesia inducing threshold hampering adequate subject blinding. Considering that tonic stimulation for pain has been shown to be efficacious for most patients on subthreshold stimulation parameters we hypothesize a similar result with it´s use on PD. The investigators aim to:

Read full original descriptionShow less

1. Produce stronger evidence on SCS efficacy for PD in regards to gait, motor scores and quality of life measures by incorporating subthreshold in a randomized cross over placebo-controlled study with a large sample. 2. Identify predictors of good response to SCS therapy by performing trans spinal magnetic stimulation (TSMS) before SCS implant and correlating the response to SCS to that of the noninvasive TSMS. 3. Better provide biomarkers of SCS therapy through functional magnetic resonance imaging and electroencephalographic mapping.

The 2 groups in the trial

  • Active stimulationTreatment being tested

    During active stimulation phase, patients will receive through the spinal cord stimulator active tonic stimulation with amplitude set to 90% of paresthesia inducing threshold, therefore allowing blinding. Patients will be evaluated after a three week wash out period with no stimulation and after three weeks of continuous active stimulation.

    Treatment: Active spinal cord stimulation

  • Sham stimulationSham treatment, for comparison

    During sham stimulation phase, patients will receive through the spinal cord stimulator a zero amplitude stimulation, therefore having no electrical current passing through epidural leads but with the program status still displayed as "on" if checked with patient's personal controller. Patients will be evaluated after a three week wash out period with no stimulation and after three weeks of continuous sham stimulation.

    Treatment: Sham spinal cord stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Spinal Cord Stimulation on Gait in Patients With Parkinson´s Disease; a Randomized, Crossover, Double Blinded, Placebo-Controlled Study
Record updated
13 May 2024